The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

Sílvia Xargay‐Torrent(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Dolors Colomer(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Oncotarget
June 8, 2015
10.18632/oncotarget.4212
Cited by 68

Related Papers

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells
|Oncogene|2019|33
Bcl-2<i>high</i>mantle cell lymphoma cells are sensitized to acadesine with ABT-199
|Oncotarget|2015|10